16094-57-8

Usage

Uses

Used in Pharmaceutical Industry:
NSC367445 is used as a PKC enzyme inhibitor for its potential role in modulating cellular processes such as cell growth, differentiation, and apoptosis. Its ability to target the PKC enzyme pathway may offer therapeutic benefits in various diseases and conditions.
Used in Anti-inflammatory Applications:
NSC367445 is used as an anti-inflammatory agent due to its potential to modulate inflammatory responses. By inhibiting the PKC enzyme, it may help reduce inflammation and associated symptoms in various inflammatory conditions.
Used in Anticancer Applications:
NSC367445 is used as an anticancer agent for its potential to inhibit the growth and proliferation of cancer cells. Its activity against the PKC enzyme may contribute to the suppression of tumor development and progression, offering a possible therapeutic approach for cancer treatment.
Used in Drug Development Research:
NSC367445 serves as a valuable compound in drug development research, providing insights into the modulation of PKC enzyme activity and its implications in various diseases. Further investigation of its pharmacological properties may lead to the discovery of novel therapeutic agents and treatment strategies.

Upstream product

• 111381-04-5 N-trifluoroacetyl-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane 
• 2801-68-5 2,5-dimethoxyphenylisopropylamine 
• 67460-68-8 1-(2,5-dimethoxy-4-nitrophenyl) propan-2-amine 
• 79315-43-8 (+/-)-N-[2-(2,5-dimethoxyphenyl)-1-methylethyl]-2,2,2-trifluoroacetamide 
• 111381-03-4 N-{2-[2,5-Dimethoxy-4-(piperidin-1-ylazo)-phenyl]-1-methyl-ethyl}-2,2,2-trifluoro-acetamide 
• 111381-01-2 N-[2-(2,5-Dimethoxy-4-nitro-phenyl)-1-methyl-ethyl]-2,2,2-trifluoro-acetamide 
• 111381-02-3 N-[2-(4-Amino-2,5-dimethoxy-phenyl)-1-methyl-ethyl]-2,2,2-trifluoro-acetamide